APA (7th ed.) Citation

Oshansky, C. M., King, J., Lu, D., Zhou, J., Pavetto, C., Horwith, G., . . . Donis, R. O. (2021). Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults. npj vaccines, 6(1), 41-8. https://doi.org/10.1038/s41541-021-00287-7

Chicago Style (17th ed.) Citation

Oshansky, Christine M., et al. "Adjuvanted Recombinant Hemagglutinin H7 Vaccine to Highly Pathogenic Influenza A(H7N9) Elicits High and Sustained Antibody Responses in Healthy Adults." Npj Vaccines 6, no. 1 (2021): 41-8. https://doi.org/10.1038/s41541-021-00287-7.

MLA (9th ed.) Citation

Oshansky, Christine M., et al. "Adjuvanted Recombinant Hemagglutinin H7 Vaccine to Highly Pathogenic Influenza A(H7N9) Elicits High and Sustained Antibody Responses in Healthy Adults." Npj Vaccines, vol. 6, no. 1, 2021, pp. 41-8, https://doi.org/10.1038/s41541-021-00287-7.